Skip to content

Physician Led Counseling in Management of Depression in Type 2 Diabetes Mellitus

Physician Led Counseling for Depression in Type 2 Diabetes Mellitus: A Randomized, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02185482
Enrollment
150
Registered
2014-07-09
Start date
2014-08-31
Completion date
2015-11-30
Last updated
2016-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Type 2 Diabetes Mellitus

Keywords

Psychological counselling, Randomized single blind study, Depression, Diabetes

Brief summary

There is a high prevalence of depression in patients with diabetes mellitus. Depression has been shown to be associated with poor self-management (adherence to diet, exercise, checking blood glucose levels) levels in patients with diabetes.To determine whether enhancing quality physician's care for depression improves both depression and diabetes outcomes in patients with depression and diabetes.

Interventions

BEHAVIORALPhysician Supported Care
OTHERUsual care

Sponsors

NMP Medical Research Institute
CollaboratorOTHER
Adwin Life Care
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Eligible patients are ambulatory, * Had adequate hearing to complete a telephone interview, * Diabetic patients screened for depression

Exclusion criteria

* Currently in care with a psychiatrist; * Diagnosis of bipolar disorder or schizophrenia; * Use of antipsychotic or mood stabilizer medication * Mental confusion on interview, suggesting significant dementia.

Design outcomes

Primary

MeasureTime frame
change in depression using SCL-90 depression scaleChange from baseline to six month

Secondary

MeasureTime frame
Glycemic control measured using glycosylated hemoglobin levelsChange from baseline to six month

Other

MeasureTime frame
Global assessment of improvement using Patient Global ImpressionChange from baseline to six months

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026